The validity of self-rated psychotic symptoms in depressed inpatients

European Psychiatry

Volumn 27, Issue 7, 2012, Pages 547-552

  Seemuller F ^a   Riedel, M ^a   Obermeier, M ^a   Schennach Wolff, R ^a   Spellmann, I ^a   Meyer, S ^a   Bauer, M ^b   Adli, M ^c   Kronmuller K ^d   Ising, M ^e   Brieger, P ^f   Laux, G ^g   Bender, W ^h   Heuser, I ^c   Zeiler, J ⁱ   Gaebel, W ^j   Moller H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^g Inn Salzach Klinikum   (Germany)

^h KLINIKUM MÜNCHEN OST   (Germany)

ⁱ Vivantes Auguste Viktoria Klinikum   (Germany)

^j HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

Depression; Psychotic symptoms; SCL 90; Self rating

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HAMILTON SCALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PSYCHOSIS; SELF EVALUATION; SYMPTOM CHECKLIST 90; VALIDITY;

ADULT; CHECKLIST; DEPRESSION; DEPRESSIVE DISORDER; DIAGNOSTIC SELF EVALUATION; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS;

EID: 84866442779     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2011.01.004     Document Type: Article

References (29)

1. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000, 157:1-45.
2. Bailey J., Coppen A. A comparison between the Hamilton Rating Scale and the Beck Inventory in the measurement of depression. Br J Psychiatry 1976, 128:486-489.
3. Bauer M., Bschor T., Pfennig A., Whybrow P.C., Angst J., Versiani M., et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007, 8(2):67-104.
4. Beck T., Ward H., Mendelsson M., Mok J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
5. Bijl R.V., Ravelli A., van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998, 33(12):587-595.
6. David A.S. Why we need more debate on whether psychotic symptoms lie on a continuum with normality. Psychol Med 2010, 1-8. [vol. First View].
7. Demyttenaere K., Desaiah D., Petit C., Croenlein J., Brecht S. Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder. Primary Care Companion J Clin Psychiatry 2009, 11(1):8-15.
8. Egli S., Riedel M., Möller H.J., Strauss A., Lage D. Creating a map of psychiatric patients based on psychopathological symptom profiles. Eur Arch Psychiatry Clin Neurosci 2009, 259(3):164-171.
9. Guy W. Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health 1976, MD revised, Rockville.
10. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6(4):278-296.
11. Johns L.C., van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001, 21(8):1125-1141.
12. Kendler K.S., Gallagher T.J., Abelson J.M., Kessler R.C. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 1996, 53(11):1022-1031.
13. McGlashan T.H., Zipursky R.B., Perkins D., Addington J., Miller T., Woods S.W., et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006, 163(5):790-799.
14. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002, 59(10):921-928.
15. Möller H.J. Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales. Pharmacopsychiatry 1991, 24(3):71-75.
16. Möller H.J. Rating depressed patients: observer- vs self-assessment. Eur Psychiatry 2000, 15(3):160-172.
17. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
18. Ochoa S., Haro J.M., Torres J.V., Pinto-Meza A., Palacin C., Bernal M., et al. What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia Study. Schizophrenia Res 2008, 102(1-3):261-269.
19. Ohayon M.M. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000, 97(2-3):153-164.
20. Pietzcker A., Gebhardt R. Depressive syndromes and scales in the AMDP-system. Acta Psychiatrica Scandinavica Suppl 1983, 310(8):65-84.
21. Pietzcker A., Gebhardt R., Strauss A., Stockel M., Langer C., Freudenthal K. The syndrome scales in the AMDP-System. Mod Prob Pharmacopsychiatry 1983, 20:88-99.
22. Rauter U.K., Leonard C.E., Swett C.P. SCL-90-R factor structure in an acute, involuntary, adult psychiatric inpatient sample. J Clin Psychol 1996, 52(6):625-629.
23. Rossler W., Riecher-Rossler A., Angst J., Murray R., Gamma A., Eich D., et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophrenia Res 2007, 92:1-14.
24. Schmitz N., Hartkamp N., Kiuse J., Franke G.H., Reister G., Tress W. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Qual Life Res 2000, 9(2):185-193.
25. Seemuller F., Riedel M., Obermeier M., Bauer M., Adli M., Kronmuller K., et al. Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur Neuropsychopharmacol 2010, 20(5):346-355.
26. van der Werf M., van Boxtel M., Verhey F., Jolles J., Thewissen V., van Os J. Mild hearing impairment and psychotic experiences in a normal aging population. Schizophrenia Res 2007, 94(1-3):180-186.
27. van Os J., Hanssen M., Bijl R.V., Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population?. Schizophrenia Res 2000, 45(1-2):11-20.
28. van Os J., Hanssen M., Bijl R.V., Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch General Psychiatry 2001, 58(7):663-668.
29. von Zerssen D. Self-rating scales for evaluation of patient's subjective state in cross-sectional and longitudinal studies of psychopathology. Archiv für Psychiatrie und Nervenkrankheiten 1973, 17(3):299-314.